☰

Qingfei Wang - Publications

Affiliations: 
2016- Biological Sciences University of Notre Dame, Notre Dame, IN, United States 
Tree Info Grants Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhao Y, Liu Z, Liu G, Zhang Y, Liu S, Gan D, Chang W, Peng X, Sung ES, Gilbert K, Zhu Y, Wang X, Zeng Z, Baldwin H, Ren G, ... ... Wang Q, et al. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1. Cell Metabolism. 35: 1688-1703.e10. PMID 37793345 DOI: 10.1016/j.cmet.2023.09.004  0.617
2023 Palakurthi B, Fross SR, Guldner IH, Aleksandrovic E, Liu X, Martino AK, Wang Q, Neff RA, Golomb SM, Lewis C, Peng Y, Howe EN, Zhang S. Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Nature Communications. 14: 2109. PMID 37055410 DOI: 10.1038/s41467-023-37727-y  0.61
2023 Wang Q, Poole RA, Opyrchal M. Understanding and targeting erythroid progenitor cells for effective cancer therapy. Current Opinion in Hematology. PMID 37052294 DOI: 10.1097/MOH.0000000000000762  0.332
2021 Guldner IH, Golomb SM, Wang Q, Wang E, Zhang S. Isolation of mouse brain-infiltrating leukocytes for single cell profiling of epitopes and transcriptomes. Star Protocols. 2: 100537. PMID 34036283 DOI: 10.1016/j.xpro.2021.100537  0.756
2021 Kim J, Wang Q, Zhang S, Yoon S. Compressed sensing-based super-resolution ultrasound imaging for faster acquisition and high quality images. Ieee Transactions On Bio-Medical Engineering. PMID 33793396 DOI: 10.1109/TBME.2021.3070487  0.385
2021 Liu Y, Yang J, Shi Z, Tan X, Jin N, O'Brien C, Ott C, Grisoli A, Lee E, Volk K, Conroy M, Franz E, Bryant A, Campbell L, Crowley B, ... ... Wang Q, et al. In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulation. Cancer Letters. PMID 33524500 DOI: 10.1016/j.canlet.2021.01.024  0.783
2020 Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC, Cho SH, Paik Y, Wang Q, Zhang S, Manning HC, Rathmell JC, Cook RS, Boothby MR, Chen J. Selective glutamine metabolism inhibition in tumor cells improves anti-tumor T lymphocyte activity in triple-negative breast cancer. The Journal of Clinical Investigation. PMID 33320840 DOI: 10.1172/JCI140100  0.579
2020 Golomb SM, Guldner IH, Zhao A, Wang Q, Palakurthi B, Aleksandrovic EA, Lopez JA, Lee SW, Yang K, Zhang S. Multi-modal Single-Cell Analysis Reveals Brain Immune Landscape Plasticity during Aging and Gut Microbiota Dysbiosis. Cell Reports. 33: 108438. PMID 33264626 DOI: 10.1016/j.celrep.2020.108438  0.665
2020 Guldner IH, Wang Q, Yang L, Golomb SM, Zhao Z, Lopez JA, Brunory A, Howe EN, Zhang Y, Palakurthi B, Barron M, Gao H, Xuei X, Liu Y, Li J, et al. CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10. Cell. PMID 33113353 DOI: 10.1016/j.cell.2020.09.064  0.722
2020 Wang S, Raybuck A, Shiuan E, Cho SH, Wang Q, Brantley-Sieders DM, Edwards D, Allaman MM, Nathan J, Wilson KT, DeNardo D, Zhang S, Cook R, Boothby M, Chen J. Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity. Jci Insight. 5. PMID 32759497 DOI: 10.1172/Jci.Insight.139237  0.577
2020 Wang Q, Gao J, Di W, Wu X. Anti-angiogenesis therapy overcomes the innate resistance to PD-1/PD-L1 blockade in VEGFA-overexpressed mouse tumor models. Cancer Immunology, Immunotherapy : Cii. PMID 32347357 DOI: 10.1007/s00262-020-02576-x  0.322
2019 Wang Q, Guldner IH, Golomb SM, Sun L, Harris JA, Lu X, Zhang S. Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer. Nature Communications. 10: 3817. PMID 31444334 DOI: 10.1038/S41467-019-11729-1  0.779
2018 Wang Q, Gao J, Wu X. Pseudoprogression and hyperprogression after checkpoint blockade. International Immunopharmacology. 58: 125-135. PMID 29579717 DOI: 10.1016/j.intimp.2018.03.018  0.321
2017 Yang J, Joshi S, Wang Q, Li P, Wang H, Xiong Y, Xiao Y, Wang J, Parker-Thornburg J, Behringer RR, Yu D. 14-3-3ζ loss leads to neonatal lethality by microRNA-126 downregulation-mediated developmental defects in lung vasculature. Cell & Bioscience. 7: 58. PMID 29118970 DOI: 10.1186/S13578-017-0186-Y  0.447
2017 Joshi S, Yang J, Wang Q, Li P, Wang H, Zhang Q, Xiong Y, Pickering BF, Parker-Thornburg J, Behringer RR, Yu D. 14-3-3ζ loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling. American Journal of Cancer Research. 7: 1654-1664. PMID 28861322  0.578
2016 Guldner IH, Yang L, Cowdrick KR, Wang Q, Alvarez Barrios WV, Zellmer VR, Zhang Y, Host M, Liu F, Chen DZ, Zhang S. An Integrative Platform for Three-dimensional Quantitative Analysis of Spatially Heterogeneous Metastasis Landscapes. Scientific Reports. 6: 24201. PMID 27068335 DOI: 10.1038/Srep24201  0.729
2015 Wang Q, Ding H, Wang H, Li P, Liu B, Zhang K. Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors. Oncology Reports. 33: 179-84. PMID 25354531 DOI: 10.3892/or.2014.3574  0.358
2014 Sahin O, Wang Q, Brady SW, Ellis K, Wang H, Chang CC, Zhang Q, Priya P, Zhu R, Wong ST, Landis MD, Muller WJ, Esteva FJ, Chang J, Yu D. Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors. Cell Research. 24: 542-59. PMID 24675532 DOI: 10.1038/Cr.2014.37  0.571
2014 Wang Q, Ding H, Liu B, Li SH, Li P, Ge H, Zhang K. Addition of the Akt inhibitor triciribine overcomes antibody resistance in cells from ErbB2/Neu-positive/PTEN-deficient mammary tumors. International Journal of Oncology. 44: 1277-83. PMID 24452693 DOI: 10.3892/ijo.2014.2271  0.407
2014 Rehman SK, Li SH, Wyszomierski SL, Wang Q, Li P, Sahin O, Xiao Y, Zhang S, Xiong Y, Yang J, Wang H, Guo H, Zhang JD, Medina D, Muller WJ, et al. 14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferation. Cancer Research. 74: 363-73. PMID 24197133 DOI: 10.1158/0008-5472.Can-13-2016  0.636
2014 Sahin O, Wang Q, Brady S, Wang H, Chang C, Wong S, Muller W, Esteva F, Chang J, Yu D. 237: Sequential application of targeted therapies guided by biomarkers overcomes therapy resistance in rapidly evolving highly aggressive mammary tumors European Journal of Cancer. 50: S55. DOI: 10.1016/S0959-8049(14)50208-0  0.499
2012 Wang Q, Li SH, Wang H, Xiao Y, Sahin O, Brady SW, Li P, Ge H, Jaffee EM, Muller WJ, Hortobagyi GN, Yu D. Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer. Cancer Research. 72: 4417-28. PMID 22773664 DOI: 10.1158/0008-5472.Can-12-1339-T  0.627
2011 Lang JY, Hsu JL, Meric-Bernstam F, Chang CJ, Wang Q, Bao Y, Yamaguchi H, Xie X, Woodward WA, Yu D, Hortobagyi GN, Hung MC. BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment. Cancer Cell. 20: 341-56. PMID 21907925 DOI: 10.1016/J.Ccr.2011.07.017  0.593
2008 Wang Q, Li M, Wang Y, Zhang Y, Jin S, Xie G, Liu Z, Wang S, Zhang H, Shen L, Ge H. RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Letters. 269: 127-38. PMID 18534745 DOI: 10.1016/j.canlet.2008.04.035  0.318
Show low-probability matches.